In the present study, we have evaluated the effects of FGF-9 treatment on vessel apoptosis, c-Kit+ve stem cell stimulation, new vessel formation, and cardiac function in post-MI nondiabetic and diabetic mice. This evidence concerns the gene FGF9 and myocardial infarction.